Next Article in Journal
Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
Next Article in Special Issue
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
Previous Article in Journal
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
Previous Article in Special Issue
Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(3), 591; https://doi.org/10.3390/pharmaceutics14030591
Action Date Notes Link
article pdf uploaded. 8 March 2022 14:50 CET Version of Record https://www.mdpi.com/1999-4923/14/3/591/pdf-vor
article xml file uploaded 9 March 2022 11:34 CET Original file -
article xml uploaded. 9 March 2022 11:34 CET Update https://www.mdpi.com/1999-4923/14/3/591/xml
article pdf uploaded. 9 March 2022 11:34 CET Updated version of record https://www.mdpi.com/1999-4923/14/3/591/pdf
article html file updated 9 March 2022 11:36 CET Original file -
article html file updated 1 August 2022 04:41 CEST Update https://www.mdpi.com/1999-4923/14/3/591/html
Back to TopTop